Antony C. Mattessich, President & CEO, Director at Ocular Therapeutix, holds 595.20K shares in Ocular Therapeutix (Ticker: OCUL), holds ― shares in Aura Biosciences Inc (Ticker: AURA).

See the Hottest Stocks Based on Insider Trading >

Antony C. Mattessich
Ocular Therapeutix (OCUL)
President & CEO, Director

Ranked #19,172 out of 98,624 Corporate Insiders

Profitable Transactions

4 out of 8 Profitable Transactions

Average Return

+9.70%

Average return per transaction

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

100.00%

OCUL

0.00%

AURA

A breakdown of Antony C. Mattessich's holdings

See the Top Stocks by Insiders

Insider Roles

Ocular Therapeutix
(OCUL)

President & CEO, Director

Aura Biosciences Inc
(AURA)

Director

Roles that Antony C. Mattessich holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

Ocular Therapeutix
(OCUL)

Rating:Informative Buy

Date:Jun 10, 2019 - Jun 10, 2020

Return:+126.00%

The most profitable trade made by Antony C. Mattessich

See the Latest Stocks Traded by Insiders

Antony C. Mattessich's Trading History

OCUL

Ocular Therapeutix

Feb 06, 2024

President & CEO, Director

Uninformative Buy

―

$2.82M

AURA

Aura Biosciences Inc

―

Director

―

List of latest transactions for each holding click on a transaction to see Antony C. Mattessich's performance on stock

See All Insider Trading from Today

Antony C. Mattessich insider profile FAQ

What is the percentage of profitable transactions made by Antony C. Mattessich?

The percentage of profitable transactions made by Antony C. Mattessich is 50%.

What is the average return per transaction made by Antony C. Mattessich?

The average return per transaction made by Antony C. Mattessich is 9.70%.

What stocks does Antony C. Mattessich hold?

Antony C. Mattessich holds: OCUL, AURA stocks.

What was Antony C. Mattessich’s latest transaction?

Antony C. Mattessich latest transaction was an Uninformative Buy of ―.

What was Antony C. Mattessich's most profitable transaction?

Antony C. Mattessich’s most profitable transaction was an Informative Buy of OCUL stock on June 10, 2019. The return on the trade was 126.00%.

What is Antony C. Mattessich's role in Ocular Therapeutix?

Antony C. Mattessich's role in Ocular Therapeutix is President & CEO, Director.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

Antony C. Mattessich Insider Profile

Antony C. Mattessich Ocular Therapeutix (OCUL)President & CEO, Director